GAITHERSBURG, Md. -– OpGen, Inc., a molecular testing and bioinformatics company, today announced the expansion of its executive management team with the appointments of former Foundation Medicine (NASDAQ: FMI) executive Kevin Krenitsky, M.D. as president, and Timothy C. Dec as interim chief financial officer. With more than 15 years of experience leading and managing global […]
BILLERICA, Mass. — — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced global availability of the ThunderBolts Myeloid Panel, a next-generation sequencing (NGS) research assay designed to rapidly detect and cost-effectively analyze genetic mutations associated with AML (Acute Myeloid Leukemia), MDS (Myelodysplastic Syndromes), MPN (Myeloproliferative Neoplasms) and […]
PHILADELPHIA — Thermo Fisher Scientific, the world leader in serving science, today unveiled new innovations for research aimed at addressing the growing need for early detection, better prognosis, and more effective cancer treatments in the future. These new products and presentations are being featured at the American Association for Cancer Research (AACR) 2015 Annual Meeting, […]
CARLSBAD, Calif. — Translational and clinical research laboratories now have access to a multi-biomarker, next-generation sequencing (NGS) panel that includes 52 solid tumor genes associated with current oncology drugs and published evidence. The Oncomine Focus Assay by Thermo Fisher Scientific (NYSE: TMO) is being featured at the American Association for Cancer Research conference taking place […]
Boston MA and Shenzhen China — BGI, the world’s largest genomics organization, announces the launch of a powerful and highly secure cloud computing platform for genomic data analysis, known as BGI Online. BGI Online provides a one-stop solution for managing NGS projects and enables users to create and run complex data analysis pipelines easily. BGI […]
Palo Alto, CA – Centrillion Technologies, a genomic technologies company, has received a SBIR grant from the National Human Genome Research Institute, part of the National Institutes of Health (NIH). The grant will help fund the company’s ongoing research efforts in the development of breakthrough genomic technologies, including phased sequencing of complete genomes using specially […]
BILLERICA, Mass. —— RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced agreements with BioTech-Europe, Diatech Pharmacogenetics srl, Labgene Scientific, and Neo-Science & Group, enabling these companies to distribute RainDance products in Central and Eastern Europe, Italy, Switzerland, the Kingdom of Bahrain, State of Kuwait, Sultanate of Oman, […]
Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer care, today announced the appointment of Scott Storrer to the position of global president. In this new role, Storrer, who joined Strand in July 2014 as president of North America, will oversee the company’s operations worldwide with a […]
Cambridge-based Congenica, a spinout from The Wellcome Trust Sanger Institute, has raised a further £2.2m with the completion of a series A round of financing by Amadeus Capital Partners’ early stage funds and the company’s initial investor Cambridge Innovation Capital. Congenica was launched in 2014 by six world leading geneticists and bio-informaticians. It has developed […]
tate College PA 16803 USA — SoftGenetics announced that following a close collaboration with RainDance Technologies Inc. (https://RainDanceTech.com/), it has incorporated customized analysis workflow templates into its NextGENe NGS software providing users of the ThunderBolts Cancer and Myeloid Panels with pre-defined settings for detecting minor allele frequencies at different sensitivity settings (1% and 5%). Use […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
